BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
30 avr. 2024 07h30 HE
|
BioRestorative Therapies, Inc
— Leading regenerative medicine and aesthetics innovators collaborate to build a vertically integrated, best-in-class biocosmeceutical platform — — Exclusive, five (5)-year agreement includes...
Hyloris élargit son Portefeuille avec un Nouveau Produit Candidat pour le Syndrome de la Bouche Brûlante
21 déc. 2023 12h30 HE
|
Hyloris Pharmaceuticals SA
Hyloris élargit son Portefeuille avec un Nouveau Produit Candidat pour le Syndrome de la Bouche Brûlante Partenariat à parts égales avec AFT Pharmaceuticals pour le Développement d'un Nouveau Produit...
Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome
21 déc. 2023 12h30 HE
|
Hyloris Pharmaceuticals SA
Hyloris Broadens Pipeline with new Product Candidate in Burning Mouth Syndrome Equal Partnership with AFT Pharmaceuticals for Development of a Novel Locally-Acting Product Candidate in Burning Mouth...
HydroGraph Signs Commercial Agreement with Leading Advanced Materials Supply Chain Firm
07 juin 2023 07h00 HE
|
Hydrograph Clean Power Inc.
VANCOUVER, British Columbia, June 07, 2023 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”), a manufacturer of high-quality nanomaterials,...
Hyloris annonce un partenariat commercial pour Maxigesic® IV dans 9 pays européens
24 janv. 2023 01h00 HE
|
Hyloris Pharmaceuticals SA
Signature d'un accord exclusif de licence et de distribution avec Salus Pharmaceuticals en Lituanie, Estonie, Lettonie, Croatie, Slovénie, Serbie, Macédoine du Nord, Monténégro et BosniePremiers...
Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries
24 janv. 2023 01h00 HE
|
Hyloris Pharmaceuticals SA
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia, Montenegro and BosniaFirst commercial...
Nemaura Medical Announces Commercial Agreement with UK Licensee
27 sept. 2021 08h00 HE
|
Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
MOBI724 signe un nouvel accord avec un partenaire commercial ayant des opérations dans plusieurs pays
15 mars 2019 08h53 HE
|
Solutions Globale Mobi724 inc.
MONTRÉAL, 15 mars 2019 (GLOBE NEWSWIRE) -- Solutions Globales MOBI724 inc. (« MOBI724 » ou la « Société ») (TSX-V:MOS, OTC QB:MOBIF), une société de technologie financière œuvrant à l’échelle...
MOBI724 Signs a New Commercial Agreement With a Business Partner With Operations in Multiple Countries
15 mars 2019 08h53 HE
|
Mobi724 Global Solutions Inc.
MONTREAL, March 15, 2019 (GLOBE NEWSWIRE) -- MOBI724 Global Solutions Inc. (“MOBI724” or the “Company”) (TSX-V: MOS) (OTCQB: MOBIF), a global Fintech company, offering a fully integrated suite of...
Mobi724 Signs a Commercial Agreement With Banco Promerica Guatemala
01 nov. 2018 11h36 HE
|
Mobi724 Global Solutions Inc.
MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Mobi724 Global Solutions Inc. (“Mobi724” or the “Company”) (TSX-V:MOS) (OTCQB:MOBIF), a global Fintech company, offering a fully integrated suite of...